- Home
- IXHL vs GSIW Comparison
IXHL vs GSIW Comparison
Compare IXHL & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | IXHL | GSIW |
|---|---|---|
| Founded | 2001 | 2016 |
| Country | Australia | Hong Kong |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.0M | 42.6M |
| IPO Year | 2024 | 2022 |
Fundamental Metrics
Financial Performance| Metric | IXHL | GSIW |
|---|---|---|
| Price | $3.44 | $29.76 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 270.0K | 6.4K |
| Earning Date | 05-15-2026 | 08-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $0.05 |
| 52 Week High | $6.39 | $38.55 |
Technical Indicators
Market Signals| Indicator | IXHL | GSIW |
|---|---|---|
| Relative Strength Index (RSI) | 45.55 | 48.04 |
| Support Level | $2.68 | $26.17 |
| Resistance Level | $3.68 | $32.67 |
| Average True Range (ATR) | 0.30 | 2.00 |
| MACD | -0.01 | -0.14 |
| Stochastic Oscillator | 35.60 | 25.00 |
Price Performance
Historical ComparisonAbout IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.